Home / Market News / $NEUP

$NEUP news and market catalysts

The 1 most recent market catalysts affecting $NEUP, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

1 catalysts 1 high impact 0 bullish 1 bearish Biotechnology

Sep 18, 2026 Corporate Catalyst Bearish Impact 92

Neuphoria Therapeutics Q4 EPS $(0.95) Misses $(0.56) Estimate, Sales $1.174M.

Neuphoria Therapeutics (NEUP) announced Q4 earnings that significantly missed analyst expectations, reporting a loss of $(0.95) per share compared to an estimated $(0.56). This 69.…

Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.